These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 21307893)

  • 1. Pharmaceutical industry must take its medicine.
    Macilwain C
    Nature; 2011 Feb; 470(7333):141. PubMed ID: 21307893
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effectiveness casts first shadows across US industry.
    Waltz E
    Nat Biotechnol; 2009 Mar; 27(3):211-2. PubMed ID: 19270651
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of the private sector in biotechnology: research and development.
    Feisee L
    Health Matrix Clevel; 2002; 12(2):357-65. PubMed ID: 12430359
    [No Abstract]   [Full Text] [Related]  

  • 4. Taking the profit out of biomedical research tools.
    Flores MA
    Nat Biotechnol; 1999 Aug; 17(8):819-20. PubMed ID: 10429252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Putting your best mode forward.
    Tsao YR; Tabtiang RK
    Nat Biotechnol; 2000 Oct; 18(10):1113-4. PubMed ID: 11017054
    [No Abstract]   [Full Text] [Related]  

  • 6. Science and the law. Working through the patent problem.
    Walsh JP; Cohen WM; Arora A
    Science; 2003 Feb; 299(5609):1021. PubMed ID: 12586928
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 8. Razing the tollbooths. A call for restricting patents on basic biomedical research.
    Stix G
    Sci Am; 2003 Apr; 288(4):37. PubMed ID: 12661312
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment: Academic return.
    Eisenstein M
    Nature; 2016 May; 533(7601):S20-1. PubMed ID: 27144604
    [No Abstract]   [Full Text] [Related]  

  • 10. Obama signs 21st Century Cures Act.
    Nat Biotechnol; 2017 Jan; 35(1):6. PubMed ID: 28072787
    [No Abstract]   [Full Text] [Related]  

  • 11. Biotechnology products and university-based science.
    Korn D; Heinig SJ
    JAMA; 2005 Jun; 293(23):2862-3; author reply 2863. PubMed ID: 15956628
    [No Abstract]   [Full Text] [Related]  

  • 12. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
    Westerlund L
    Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544
    [No Abstract]   [Full Text] [Related]  

  • 13. In tight times, companies fill the funding gap.
    Savage N
    Cell; 2015 May; 161(4):699-701. PubMed ID: 25957675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent crunch pending.
    Wadman M
    Nature; 2007 Oct; 449(7163):651. PubMed ID: 17968400
    [No Abstract]   [Full Text] [Related]  

  • 15. Conflict-of-interest policy at the National Institutes of Health: the pendulum swings wildly.
    DeRenzo EG
    Kennedy Inst Ethics J; 2005 Jun; 15(2):199-210. PubMed ID: 16149208
    [No Abstract]   [Full Text] [Related]  

  • 16. The antibiotic pipeline.
    Kunin CM
    N Engl J Med; 2004 Nov; 351(19):2019-20. PubMed ID: 15525731
    [No Abstract]   [Full Text] [Related]  

  • 17. Patent fight sparks biological warfare in the drug industry.
    Fortune; 2000 Jul; 142(3):40, 42. PubMed ID: 11066662
    [No Abstract]   [Full Text] [Related]  

  • 18. Patent protection for medical technologies: why some and not others?
    Melzer D
    Lancet; 1998 Feb; 351(9101):518-9. PubMed ID: 9482467
    [No Abstract]   [Full Text] [Related]  

  • 19. US policy may encourage counterfeit drugs.
    Bouchie A
    Nat Biotechnol; 2003 Feb; 21(2):121. PubMed ID: 12560826
    [No Abstract]   [Full Text] [Related]  

  • 20. The NIH budget and the future of biomedical research.
    Loscalzo J
    N Engl J Med; 2006 Apr; 354(16):1665-7. PubMed ID: 16625006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.